173 related articles for article (PubMed ID: 4774750)
1. [Comparative study of bronchodilating effects and action on the cardiovascular system of 2 sympathomimetic agents: berotec and alupent].
Zieliński J; Chodosowska E; Koziorowski A
Gruzlica; 1973 Dec; 41(12):1249-58. PubMed ID: 4774750
[No Abstract] [Full Text] [Related]
2. A comparison of Berotec (Th1165a) and Salbutamol aerosols.
McLeod J; Selman J
N Z Med J; 1973 Sep; 78(498):209-10. PubMed ID: 4519004
[No Abstract] [Full Text] [Related]
3. [Comparative studies on the effect of Aludrin and Alupent as spray aerosols].
Fischer M; Mielke U
Med Klin; 1965 Nov; 60(45):1824-7. PubMed ID: 5887818
[No Abstract] [Full Text] [Related]
4. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
Rozniecki J; Grabski W
Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
[No Abstract] [Full Text] [Related]
5. Metaproterenol, a potent and safe bronchodilator.
Hurst A
Ann Allergy; 1973 Oct; 31(10):460-6. PubMed ID: 4148976
[No Abstract] [Full Text] [Related]
6. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
Pelz HH
Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
[No Abstract] [Full Text] [Related]
7. [Bronchodilating effects of an orciprenaline derivative].
Anastasatu C; Jienescu Z; Duţu S
Ftiziologia; 1972; 21(6):593-8. PubMed ID: 4644837
[No Abstract] [Full Text] [Related]
8. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction].
Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E
Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138
[No Abstract] [Full Text] [Related]
9. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
Verstraeten JM
Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
[No Abstract] [Full Text] [Related]
10. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
[No Abstract] [Full Text] [Related]
11. [Bronchodilator effect of fenoterol. Duration of activity and use in the basic treatment of bronchospasm].
Dierckx JP; Gillard C; Gossart R
Brux Med; 1974 May; 54(5):297-301. PubMed ID: 4429838
[No Abstract] [Full Text] [Related]
12. [Comparative bronchodilator effects of inhaled terbutaline aerosols and other beta-adrenergics].
Roberts M; Petit JM
Acta Tuberc Pneumol Belg; 1971; 62(2):180-91. PubMed ID: 4398796
[No Abstract] [Full Text] [Related]
13. [Bronchodilating effect of Berotec in bronchial asthma].
Adamek T; Czerniawska-Mysik G; Szczeklik A
Pol Tyg Lek; 1974 Jan; 29(3):111-2. PubMed ID: 4594955
[No Abstract] [Full Text] [Related]
14. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
Anastasatu C; Duţu S
Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
[No Abstract] [Full Text] [Related]
15. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
Sorbini CA; Todisco T; Boschetti E
Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
[No Abstract] [Full Text] [Related]
16. Comparison of metaproterenol and isoproterenol aerosols: spirometric evaluation after two months' therapy.
Chervinsky P; Belinkoff S
Ann Allergy; 1969 Dec; 27(12):611-6. PubMed ID: 5387334
[No Abstract] [Full Text] [Related]
17. [Evaluation of the bronchospasmolytic activity of alupent and ipradol].
Makel'skiĭ VV; Iartsev SS
Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508
[No Abstract] [Full Text] [Related]
18. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
Heller K
Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
[No Abstract] [Full Text] [Related]
19. [Mechanism of action and indications for administration of some bronchodilator agents].
Nikodýmová L; Růzicka J
Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128
[No Abstract] [Full Text] [Related]
20. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
